Related references
Note: Only part of the references are listed.The Δ133p53 Isoforms, Tuners of the p53 Pathway
Sebastien M. Joruiz et al.
CANCERS (2020)
Metabolic coordination of T cell quiescence and activation
Nicole M. Chapman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
T cell stemness and dysfunction in tumors are triggered by a common mechanism
Suman Kumar Vodnala et al.
SCIENCE (2019)
The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases
Thineskrishna Anbarasan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On-or Off-Target Autoimmunity In Vivo
Hakim Echchannaoui et al.
MOLECULAR THERAPY (2019)
T-cell Immunoglobulin and ITIM Domain Contributes to CD8+ T-cell Immunosenescence
Yangzi Song et al.
AGING CELL (2018)
TIGIT immune checkpoint blockade restores CD8(+) T-cell immunity against multiple myeloma
Camille Guillerey et al.
BLOOD (2018)
T cell senescence and CAR-T cell exhaustion in hematological malignancies
Dimitri Kasakovski et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Delta 133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling
Hamish Campbell et al.
NATURE COMMUNICATIONS (2018)
Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade
Simone A. Minnie et al.
BLOOD (2018)
CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer
Weiling He et al.
CANCER RESEARCH (2017)
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
Rigel J. Kishton et al.
CELL METABOLISM (2017)
Adoptive T Cell Therapy: An Overview of Obstacles and Opportunities
Erez Nissim Baruch et al.
CANCER (2017)
Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells
Izumi Horikawa et al.
CELL DEATH AND DIFFERENTIATION (2017)
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Michael D. Buck et al.
CELL (2016)
p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration
C. Turnquist et al.
CELL DEATH AND DIFFERENTIATION (2016)
Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade
H. Suen et al.
LEUKEMIA (2016)
Emerging concepts of T cell metabolism as a target of immunotherapy
Chih-Hao Chang et al.
NATURE IMMUNOLOGY (2016)
An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells
Diana Knies et al.
ONCOTARGET (2016)
p53 Isoforms: Key Regulators of the Cell Fate Decision
Sebastien M. Joruiz et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage
Lu Gong et al.
CELL RESEARCH (2015)
TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients
Joe-Marc Chauvin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
Connie P. M. Duong et al.
MOLECULAR IMMUNOLOGY (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells
Sian M. Henson et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang et al.
CELL (2013)
T Cell Replicative Senescence in Human Aging
Jennifer P. Chou et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
Abdul M. Mondal et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Gene-engineered T cells for cancer therapy
Michael H. Kershaw et al.
NATURE REVIEWS CANCER (2013)
Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity
V. Marcel et al.
CELL DEATH AND DIFFERENTIATION (2012)
Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses
Jinxiong Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform
Tania L. Slatter et al.
BLOOD (2011)
Biological functions of p53 isoforms through evolution: lessons from animal and cellular models
V. Marcel et al.
CELL DEATH AND DIFFERENTIATION (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
Coexpression of the T-cell receptor constant α domain triggers tumor reactivity of single-chain TCR-transduced human T cells
Ralf-Holger Voss et al.
BLOOD (2010)
p53 Research: The Past Thirty Years and the Next Thirty Years
David Lane et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells
Sian M. Henson et al.
BLOOD (2009)
p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
Kaori Fujita et al.
NATURE CELL BIOLOGY (2009)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
Modulation of mammalian life span by the short isoform of p53
B Maier et al.
GENES & DEVELOPMENT (2004)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
